EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Employment Status Among Brazilian Women With Estrogen Receptor‐Positive Nonmetastatic Breast Cancer

Daniele Assad-Suzuki iD, Luciana Castro Garcia Landeiro, Danielle Laperche-Santos iD, Heloisa Resende, Fernanda Cesar Moura, Sulene Cunha Sousa Oliveira, Andrea Kazumi Shimada, Renata Arakelian, Anna Luiza Zapalowski Galvão, Bruno Santos Wance de Souza, Amanda Guimarães Castro Custódio, Monalisa Ceciliana Freitas Moreira de Andrade und 11 weitere

Cancer Medicine · 2025

DOI: 10.1002/cam4.71306 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, 2025. Verfasst von Daniele Assad-Suzuki und 22 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Sírio-Libanês, Brasília, Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms, Employment, Receptors, Estrogen, Return to Work. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Employment is a critical determinant of quality of life, social reintegration, and financial stability for breast cancer survivors. International studies have shown that return‐to‐work (RTW) rates vary widely, ranging from 27% to over 80% within the first 3 years postdiagnosis, and are strongly influenced by sociodemographic and systemic factors. In Brazil, however, there is a scarcity of data on employment outcomes after breast cancer, despite pronounced disparities in healthcare access between public and private systems. Understanding these dynamics is crucial to identify vulnerable groups and to inform strategies that promote equitable reintegration into the workforce.

Methods

We conducted a multicenter cross‐sectional study including 454 women with nonmetastatic ER+ breast cancer who were employed at diagnosis and receiving endocrine therapy. Employment status, sociodemographic and clinical variables, and quality‐of‐life scores were collected through patient‐reported questionnaires and medical records. Univariate and multivariate generalized logit models were applied.

Results

Among 774 participants, 454 (67.1%) were employed at diagnosis. Of these, 87 (19.2%) continued working during treatment, 233 (51.54%) stopped and returned, and 134 (29.29%) stopped and did not return. Compared with privately treated patients who remained employed, those treated in public hospitals had significantly higher odds of stopping work and returning (OR = 5.93) and of stopping work and not returning (OR = 2.39). Younger age (≤ 60 years) was associated with permanent work interruption (OR = 2.39). Lower education was associated with temporary interruption (OR = 3.12). Treatment duration ≥ 2 years was associated with not returning to work (OR = 2.18).

Conclusions

Treatment in public hospitals, lower education, younger age, and prolonged treatment were associated with a higher risk of job loss. Addressing barriers and fostering workplace adaptations is vital for improving return‐to‐work rates among cancer survivors, as nearly one‐third do not return to work within 2 years postdiagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEmploymentReceptors, EstrogenReturn to WorkHumansFemaleBrazilMiddle AgedCross-Sectional StudiesQuality of LifeAdultAgedCancer SurvivorsSurveys and Questionnaires

Stichwörter der Autor:innen

breast canceremploymentendocrine therapyquality of lifereturn to work

Substanzen

Receptors, Estrogen

Autor:innen und Institutionen

  • Hospital Sírio-Libanês, Brasília, Brazil.
  • Grupo Brasileiro de Estudos Em Câncer de Mama- GBECAM, Porto Alegre, Brazil.
  • Oncoclínicas & co, Salvador, Brazil.
  • Oncoclínicas & co, Goiânia, Brazil.
  • Centro Universitário de Volta Redonda, UniFOA, Volta Redonda, Brazil.
  • Instituto Hospital de Base Do Distrito Federal, Brasília, Brazil.

ORCID-Profile: Daniele Assad-Suzuki, Danielle Laperche-Santos, Yuri Cardoso Rodrigues Beckedorff Bittencourt, Carlos Eduardo Paiva

Zitieren

APA

Assad-Suzuki, D., Landeiro, L. C. G., Laperche-Santos, D., Resende, H., Moura, F. C., Oliveira, S. C. S., Shimada, A. K., Arakelian, R., Galvão, A. L. Z., de Souza, B. S. W., Custódio, A. G. C., de Andrade, M. C. F. M., Cardoso Rodrigues Beckedorff Bittencourt, Y., Magalhães, M. C. F., Souza, C. P., Paiva, C. E., Signorini, P. A., Carvalho, A. V., Pereira, D. J., …, & Barroso-Sousa, R. (2025). Employment Status Among Brazilian Women With Estrogen Receptor‐Positive Nonmetastatic Breast Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.71306

Vancouver

Assad-Suzuki D, Landeiro LCG, Laperche-Santos D, Resende H, Moura FC, Oliveira SCS, et al. Employment Status Among Brazilian Women With Estrogen Receptor‐Positive Nonmetastatic Breast Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.71306

BibTeX
@article{AssadSuzuki2025,
  author = {Assad-Suzuki, Daniele and Landeiro, Luciana Castro Garcia and Laperche-Santos, Danielle and Resende, Heloisa and Moura, Fernanda Cesar and Oliveira, Sulene Cunha Sousa and Shimada, Andrea Kazumi and Arakelian, Renata and Galvão, Anna Luiza Zapalowski and de Souza, Bruno Santos Wance and Custódio, Amanda Guimarães Castro and de Andrade, Monalisa Ceciliana Freitas Moreira and Cardoso Rodrigues Beckedorff Bittencourt, Yuri and Magalhães, Maria Cristina Figueroa and Souza, Cristiano de Pádua and Paiva, Carlos Eduardo and Signorini, Poliana Albuquerque and Carvalho, Ariane Vieira and Pereira, Daniela Jessica and Albaneze, Laura Cereser and Nogueira-Rodrigues, Angélica and Rosa, Daniela Dornelles and Barroso-Sousa, Romualdo},
  title = {Employment Status Among Brazilian Women With Estrogen Receptor‐Positive Nonmetastatic Breast Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71306}
}
Kostenlos starten →